Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder, the Department of Health and Human Services yesterday.

HHS said it will publish updates to its that expands access to medication-assisted treatment by exempting physicians from certain certification requirements.

The exemptions apply to physicians treating patients in states where they are authorized to practice medicine; physicians, meanwhile, will be limited to treating 30 patients with buprenorphine for OUD at any one time, not including hospital-based physicians, such as those in emergency departments.

The new policy applies only to the prescription of drugs or formulations covered under the X-waiver and physicians must place an "X" on the prescription, which must clearly identify it as being written for OUD.

 

 

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…